Subtype

Male Reproductive System Neoplasm

Non-malignant1,533 active trials27 approved drugs58 evidence items

NCIt: C3054

Research activity

PubMed record counts

Each count is the number of PubMed records returned by the exact query shown, at the time it was run. Counts are research-activity signals, not quality measures.

Data not yet available

No PubMed query has been run for this entity. Counts require a MeSH-anchored query built from the entity's terminology mappings; the query string is stored with each count so it can be reproduced.

What CancerIndex knows

Literature

Linked publications (287)

Publications linked to this entity or its descendants, newest first, 25 per page. Link method and validation status are shown; 'candidate' links have not been reviewed.

pubmedPublishedShowing 76–100 of 287 publications · bibliographic data as recorded by PubMed; abstracts are not reproduced.

Association of androgen deprivation therapy and acute kidney injury in patients with prostate cancer: a systematic review and meta-analysis of 72,980 patients.
Iago Zang Pires, Alexandre Yamada Fujimura, Marília Oberto da Silva Gobbo et al. · Cancer Chemother Pharmacol · Sep 24, 2026 · PMID 42786231 · candidate dictionary pubmed
How to Biopsy in Prostate Cancer Screening and Early Detection and Who Needs Antibiotics.
Pinky Kotecha, Jim Hu, Alastair Lamb · Eur Urol Focus · Sep 24, 2026 · PMID 42786059 · candidate dictionary pubmed
Renal Function Decline After 177Lu-PSMA-617 Versus Taxane-Based Chemotherapy in Patients with Metastatic Castration-Resistant Prostate Cancer: A Propensity Score Analysis.
Natasha Sheheryar, Yalda Nikanpour, Sandhya Manohar et al. · J Nucl Med · Sep 24, 2026 · PMID 42785953 · candidate dictionary pubmed
Association of ATM Alterations with Outcomes After 177Lu-PSMA-617 Treatment in Patients with Metastatic Castration-Resistant Prostate Cancer.
Vikrant Mahajan, Lauren Yu, Lily Kollitz et al. · J Nucl Med · Sep 24, 2026 · PMID 42785951 · candidate dictionary pubmed
Phase 1 Dose-Escalation Study of the Rapid-Clearance Radioligand [177Lu]Lu-P17-087 in Metastatic Castration-Resistant Prostate Cancer: Dosimetry, Safety, and Preliminary Efficacy.
Ruiyue Zhao, Mingzhao Li, Jie Lv et al. · J Nucl Med · Sep 24, 2026 · PMID 42785946 · candidate dictionary pubmed
Cancer-specific mortality in high-risk or very high-risk prostate cancer patients treated with cryotherapy vs. external beam radiation therapy.
Leonardo Quarta, Michele Petix, Maximilian Filzmayer et al. · World J Urol · Sep 24, 2026 · PMID 42782373

· candidate dictionary

pubmed

Retraction Note: SULF2 overexpression positively regulates tumorigenicity of human prostate cancer cells.

Carolina M Vicente, Marcelo A Lima, Helena B Nader et al. · J Exp Clin Cancer Res · Sep 24, 2026 · PMID 42778945 · candidate dictionary pubmed

Integrated transcriptomic and functional analyses identify PRR7 as a therapeutic target that associated with Wnt/β-catenin signaling and docetaxel resistance in prostate cancer.

Wei Sun, Yuheng Si, Lu Hong et al. · Biochem Biophys Res Commun · Sep 24, 2026 · PMID 42542043 · candidate dictionary pubmed

Challenging the Omission and Restriction of Mohs Micrographic Surgery in National Comprehensive Cancer Network Guidelines for Vulvar Cancer, Penile Cancer, and Kaposi Sarcoma.

Daniel J Lewis · Dermatol Surg · Sep 22, 2026 · PMID 42766305 · candidate dictionary pubmed

Quantity Improves Quality: Better Outcomes for Patients with Testicular Cancer Through Centralised Care: Recommendations from the European Association of Urology Guidelines Panel on Testicular Cancer.

Christoph Oing, Hege Sagstuen Haugnes, Axel Heidenreich · Eur Urol Oncol · Sep 21, 2026 · PMID 42767873 · candidate dictionary pubmed

Which penile cancer patients with metastasis in a sentinel node may be spared inguinal lymph node dissection without compromising oncological safety? Development of a low-risk selection model.

J Mølsted, A B Als, J B Jensen et al. · Int Urol Nephrol · Sep 19, 2026 · PMID 42762369 · candidate dictionary pubmed

MH-Penile-002: a phase II, prospective, single-arm trial of neoadjuvant anti-EGFR antibody-drug conjugate plus PD-1 inhibitor in penile cancer with challenging penile preservation or regional lymph node metastasis.

Jia-Yao Wang, Yan-Xiang Shao, Li-Li Yang et al. · Future Oncol · Sep 18, 2026 · PMID 42757773 · candidate dictionary pubmed

Beyond the T-Score: Reconsidering the Timing of Bone-Protective Therapy in Men Receiving Androgen Deprivation Therapy for Hormone-Sensitive Prostate Cancer.

Ricaurte Crespo-Trevino, Ann Malbas · J Urol · Sep 18, 2026 · PMID 42758864 · candidate dictionary pubmed

Clarifying risk and treatment trajectories in ductal prostate cancer.

Ying Zhang, Yun Zhuge · World J Urol · Sep 18, 2026 · PMID 42758229 · candidate dictionary pubmed

BUB1B Mitotic Kinase Dependency Reveals CENP-E Inhibition as a Tractable Approach for Castration and Enzalutamide Resistant Prostate Cancer.

Maria J Martinez, Cynthia Blanco, Nahuel Peinetti et al. · Cancer Res · Sep 18, 2026 · PMID 42757823 · candidate dictionary pubmed

Functional outcomes and biochemical control after radical prostatectomy versus irreversible electroporation for localized prostate cancer.

Zhi-Yu Xia, Jia-Cheng Xiang, Yu-Xuan Yang et al. · iScience · Sep 18, 2026 · PMID 42755971 · candidate dictionary pubmed

Advancements and future directions in transforming therapies of prostate cancer.

Jinge Zhao, Bo Tang, Hao Zeng et al. · Chin Med J (Engl) · Sep 18, 2026 · PMID 42754954 · candidate dictionary pubmed

The bone metastatic niche enhances GJA1-20k expression and mitochondrial remodeling in metastatic prostate cancer cells.

Sarah Fournier, Nicolas Delannoye, Isabelle Courtin et al. · Biochem Biophys Res Commun · Sep 17, 2026 · PMID 42497839 · candidate dictionary pubmed

Bipolar Androgen Therapy as a Potential Mechanistic Bridge to Enhance PARP Inhibitor Efficacy in Prostate Cancer.

Jhen-Hao Jhan, Jiun-Hung Geng, Hung-Lung Ke et al. · Kaohsiung J Med Sci · Sep 17, 2026 · PMID 42753176 · candidate dictionary pubmed

Genomic and Transcriptomic Correlates of Deep PSA Response in Patients with Metastatic Androgen Pathway Modulation-Sensitive Prostate Cancer.

Rana R McKay, Deepak Kilari, Binyam Yilma et al. · Oncologist · Sep 17, 2026 · PMID 42752828 · candidate dictionary pubmed

Survival Outcomes by Frailty and Comorbidities in Veterans Treated With Abiraterone and Enzalutamide for Metastatic Castration-Resistant Prostate Cancer.

Meghana Yellanki, Jennifer La, Danne C Elbers et al. · Prostate · Sep 17, 2026 · PMID 42752817 · candidate dictionary pubmed

Trends in Prebiopsy MRI Utilization for Prostate Cancer Detection.

Stephen Rhodes, Spyridon P Basourakos, Jim C Hu et al. · JAMA Oncol · Sep 17, 2026 · PMID 42752749 · candidate dictionary pubmed

Combination of PARP inhibitor olaparib and a vascular disrupting agent reduces tumor growth in a preclinical model of prostate cancer.

Evangelia Sereti, Susan Evans-Axelsson, Jan Törnell et al. · Cancer Chemother Pharmacol · Sep 17, 2026 · PMID 42752641 · candidate dictionary pubmed

Targeting tryptophan hydroxylase 1 restricts growth and suppresses plasticity in neuroendocrine prostate cancer.

Jing Wei, Jing Wang, Jingrui Chen et al. · J Clin Invest · Sep 17, 2026 · PMID 42752508 · candidate dictionary pubmed

Precision Selection for Targeted Radionuclide Therapy in Prostate Cancer: Biparametric MRI Radiomics Combined with Serum Bone Turnover Biomarkers for Predicting Postoperative Bone Metastasis.

Yan Liu, Weiwei Hou, Lei Xie et al. · Cancer Biother Radiopharm · Sep 17, 2026 · PMID 42750630 · candidate dictionary pubmed